Patient P-03482

Synthetic patientONX-7 · Day 122 · 25–34 · F · baseline S05Steering view · 3D Open companion preview

Therapy response

Improving

Tolerance

Favorable

GI state

Deteriorating

Inflammatory state

Favorable

Nutritional resilience

Favorable

Discontinuation risk

31%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 ONX-7 started — Baseline state S05
Day 44 AD-05 recommended — Adherence Support AD-05
Day 45 Patient accepted — Started AD-05 in the companion
Day 50 No meaningful change — Adherence Support AD-05

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

GI instability+11

What helped?

Adherence Support AD-05Day 44
Result: no meaningful change

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Energy level

Daily log

5.6/10

improving · +0.6 vs previous 14 d

Stress level

Daily log

4.5/10

improving · -0.8 vs previous 14 d

Pessimism score

Daily log

3.7/10

improving · -0.7 vs previous 14 d

Sleep quality

Wearable

18.2/100

improving · +5.1 vs previous 14 d

Libido

Daily log

4.2/10

improving · +0.7 vs previous 14 d

HRV

Wearable

30.4 ms

improving · +2.5 vs previous 14 d

Toxicity

Blood

19.8/100

improving · -5.1 vs previous 14 d

This trajectory is doing well — what to keep, what to watch

Steering view →

Heading towards restoration · 76 from the failing basin, 12 from restoration.

Good elements to keep

Adherence Support AD-05
intervention · steering +8.1
Butyrate producers intact
hidden · steering +7.5
Protein (supports)
perturbation · steering +7.1
Protein
supporter · GI -3.7 next day

Main detractors to watch

Alcohol
perturbation · steering -4.6
Poor-sleep week
perturbation · steering -3
Low-HRV stretch
perturbation · steering -2.7
Dietary drift
perturbation · steering -2.6
Alcohol
detractor · GI +2.8 next day

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-3.7supporter · 95%
Alcohol
+2.8detractor · 95%
Histamine load
-1no signal · 23%
Dietary fat load
-0.7no signal · 16%
Lactose
+0.7no signal · 17%
Caffeine
0no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
Autonomic recovery ↓20
- WearableShort sleep window
Inflammatory signalling ↓15
- WearableHRV 30 ms, trending down
Mucosal barrier integrity ↓10
- WearableSleep 5.6 h, below personal baseline

DNA

Fictional pharmacogenomic panel

CYP2D6 Normal metabolizer
Expected exposure
MTHFR C677T
Reduced folate turnover

Microbiome

Shannon diversity 4.5 · butyrate capacity 72/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiLow
Bacteroides fragilisNormal
Bifidobacterium longumLow
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 33 ms
Sleep: 6.0 h
Steps: 5,959
Resting HR: 65 bpm

Daily log: GI score 24, nutritional resilience 66, adherence 91.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-03057	48%	S14	NP-02	improved	64
P-03178	43%	S11	GI-04	improved	54
P-03252	42%	S13	SC-12	improved	68
P-03144	38%	S16	HY-01	improved	52
P-03208	38%	S02	BR-03	improved	57
P-03328	38%	S15	GI-04	improved	59
P-03374	38%	S19	ME-01	improved	55
P-03179	37%	S05	GI-04	improved	52
P-03213	35%	S02	DT-01	improved	59
P-03255	35%	S01	HY-01	improved	53
P-03473	35%	S07	DT-01	improved	70
P-03188	33%	S13	HY-01	improved	79